Pola Peresepan Penggunaan Obat Ketorolak Injeksi pada Pasien Rawat Inap di Rumah Sakit X Kota Tangerang Periode Januari-Juni 2021

Rosalina, Rizka Irvania (2022) Pola Peresepan Penggunaan Obat Ketorolak Injeksi pada Pasien Rawat Inap di Rumah Sakit X Kota Tangerang Periode Januari-Juni 2021. Diploma thesis, Universitas Pelita Harapan.

Preview	Text (Title.pdf) Title.pdf.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (134kB) | Preview
Preview	Text (Abstract.pdf) Abstract.pdf.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (336kB) | Preview
Preview	Text (ToC.pdf) ToC.pdf.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (204kB) | Preview
Preview	Text (Chapter1.pdf) Chapter1.pdf.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (43kB) | Preview
	Text (Chapter2.pdf) Chapter2.pdf.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (287kB)
	Text (Chapter3.pdf) Chapter3.pdf.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (300kB)
	Text (Chapter4.pdf) Chapter4.pdf.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (391kB)
	Text (Chapter5.pdf) Chapter5.pdf.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (36kB)
Preview	Text (Bibliography) Bibliography.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (264kB) | Preview
	Text (Appendices) Appendices.pdf Restricted to Repository staff only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (2MB)

Abstract

Nonsteroidal Anti-Inflammatory Drugs (NSAID) merupakan obat yang berkhasiat analgesik, antipiretik, dan antiinflamasi, dengan mekanisme kerja menghambat aksi enzim ciclooxygenase (COX). Salah satu contoh obat golongan NSAID adalah ketorolak, ketorolak tersedia dalam sediaan injeksi. Dalam mengatasi atau membatasi penggunaan obat yang tidak rasional, ditetapkan suatu sistem yaitu Automatic Stop Order (ASO) dan berlaku untuk obat-obatan tertentu yang dianggap obat kuat / potent yang memerlukan tinjauan rutin. Ketorolak injeksi termasuk dalam drug list ASO dengan penggunaan maksimal 5 hari. Oleh karena itu, peneliti melakukan penelitian kesesuaian peresepan ketorolak injeksi yang diberikan kepada pasien rawat inap. Penelitian dilakukan secara observasional deskriptif retrospektif dengan cross-sectional atau cara pengumpulan data yang dilakukan dengan mengamati objek penelitian tanpa memberikan perlakuan kepada subjek, melainkan fenomena yang telah terjadi sebelumnya secara sistematis dan akurat. Waktu penelitian dilakukan pada Mei-Juni 2022 dengan menggunakan teknik random sampling sebanyak 154 sampel. Data demografi yang didapatkan berdasarkan jenis kelamin perempuan lebih besar (53%), jumlah kelompok usia paling banyak 26-35 tahun (24%), diagnosis atau komplikasi penyakit lebih banyak pasien Covid-19 7 orang (4,54%), batu ginjal, kanker payudara dan nyeri perut dengan jumlah yang sama sebesar 6 orang (3,9%). Lama penggunaan ketorolak injeksi sudah sesuai ASO tidak > 5 hari, penggunaan paling banyak 1-2 hari 90 orang (58,44%) dengan dosis dan frekuensi 1 sampai 3 kali sehari 30 mg, jaminan kesehatan menunjukkan data paling banyak pasien BPJS 44 orang (28,56%) dan jumlah terbesar pasien berada di ruang perawatan lantai lima. / Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are drugs that have analgesic, antipyretic, and anti-inflammatory properties, with the mechanism of action of inhibiting the action of the ciclooxygenase (COX) enzyme. One example of an NSAID class of drugs is ketorolac, ketorolac is available in injection preparations. In overcoming or limiting the irrational use of drugs, a system is established, namely the Automatic Stop Order (ASO) and applies to certain drugs that are considered strong/potent drugs that require regular reviews. Ketorolac injection is included in the ASO drug list with a maximum use of 5 days. Therefore, researchers conducted a study on the suitability of prescribing ketorolac injection given to hospitalized patients. The research was conducted by retrospective descriptive observation with cross-sectional or data collection method by observing the research object without giving treatment to the subject, but phenomena that had occurred previously systematically and accurately. The time of the study was carried out in May-June 2022 using a random sampling technique of 154 samples. Demographic data obtained based on female gender is greater (53%), the number of age groups is at most 26-35 years (24%), diagnosis or disease complications are more COVID-19 patients 7 people (4.54%), kidney stones , breast cancer and abdominal pain with the same number of 6 people (3.9%). The duration of the use of ketorolac injection is according to the ASO not > 5 days, the maximum use is 1-2 days 90 people (58.44%) with a dose and frequency of 1 to 3 times a day 30 mg, health insurance shows that the most BPJS patients are 44 people ( 28.56%) and the largest number of patients were in the fifth floor treatment room.

Actions (login required)

View Item